Classification: Synthetic growth-hormone-releasing hormone (GHRH) analogue; a research peptide with label-dependent variants.
CJC-1295 is a synthetic peptide designed as an analogue of growth-hormone-releasing hormone. It belongs to research into GHRH-receptor signaling and growth-hormone biology. DAC and no-DAC descriptions can refer to materially different variants.
The calculator performs concentration arithmetic from visitor-entered values. It does not identify an unlabeled material, decide which variant is present, or infer a product specification. Enter the amount and liquid volume from the visitor’s documentation.
Changing the liquid volume changes mass per millilitre because the same entered mass is distributed across a different volume. Syringe-scale units describe volume; they do not identify CJC-1295 mass without concentration.
Peer-reviewed human studies describe pharmacokinetic and pharmacodynamic observations for long-acting CJC-1295, including changes in growth-hormone-axis biomarkers. A ClinicalTrials.gov record describes an investigational study in people with HIV-associated visceral obesity. Those records document research activity, not a general finding of benefit, safety, or suitability.
The albumin-binding concept is context for the DAC designation, but it is not a reason to assume that every item labeled CJC-1295 has the same behavior. Study populations, formulations, endpoints, and variant identity limit comparison.
As reviewed on the date below, the evidence includes early human research and registered clinical investigation, but CJC-1295 is not treated by this configuration as an established approved therapy. FDA’s Pharmacy Compounding Advisory Committee materials describe safety concerns and evaluate multiple CJC-1295-related bulk substances independently. Committee consideration, a substance listing, or a clinical-trial record is not an authorization to market a product.
The regulatory position can depend on substance form, jurisdiction, intended use, and current agency action. This calculator makes no claim about legality, quality, identity, or clinical suitability.
For mass entries, 1 mg = 1,000 mcg. Concentration is normalized mass divided by the entered liquid volume. U-100 means 100 units per mL, and U-40 means 40 units per mL; those are display-scale definitions, not CJC-1295 information.
The DAC or no-DAC label choice does not change the arithmetic formula, but it can change the identity of what the label describes. The labelVariantPrompt exists to prevent the interface from silently treating variants as interchangeable.
DAC and no-DAC descriptions can identify different research variants. The prompt records what the visitor’s own label says; it does not decide whether the material is authentic or interchangeable.
No. Similar growth-hormone-axis terminology does not establish identical sequence or modification. Verify the exact identity from authoritative product documentation rather than relying on a nickname.
It uses the entered mass, liquid volume, amount to calculate, and syringe display scale to calculate concentration, represented volume, and scale units.
PepLedger does not determine or recommend an amount. It performs arithmetic using values entered by the visitor.
Syringe units express a volume scale. The mass represented by that volume depends on the concentration calculated from the visitor’s entries.
PepLedger calculates concentration, liquid volume and syringe-scale position exclusively from the values you enter. It does not choose or recommend an amount.
View our calculation methodology and editorial standards
Last updated: September 13, 2026